CEO Blog : Clinical Trials

Posted on January 3rd, 2017 by Blog Author

We have yet to treat our first patient with NOX66, but the clinical program has started. Splitting hairs? Perhaps, but starting any first-in-man study is an exercise in logistics. Getting a program of 5 clinical studies up and running is a considerable task. We have cleared the major hurdles on all 5 studies: viz. manufacture […]

Read More